Insulin resistance developing in children with IDDM

Diabetes Care
|May 1, 1982
PubMed

Insights

Three children with insulin-dependent diabetes mellitus (IDDM) developed insulin resistance (IR). Two cases involved high insulin antibodies, while one had hyperthyroidism, highlighting diverse causes of IR in pediatric diabetes.

Area of Science:

  • Pediatric Endocrinology
  • Metabolic Disorders
  • Immunology

Background:

  • Insulin resistance (IR) is a complex condition impacting glycemic control in children with insulin-dependent diabetes mellitus (IDDM).
  • Understanding the diverse etiologies and clinical presentations of IR is crucial for effective management in pediatric populations.

Observation:

  • A review of 1000 children with IDDM identified three cases of new-onset insulin resistance.
  • One patient with IDDM and cystic fibrosis, and another typical IDDM patient, presented with high insulin antibody titers and responded to sulfated insulin.
  • A third patient with IDDM and hyperthyroidism showed IR controlled by propylthiouracil, despite high anti-insulin antibodies.

Findings:

  • Among 29 reported children with IDDM and IR, 71% had elevated insulin antibodies.
  • Associated illnesses were present in 41% of these pediatric patients.
  • Outcomes varied, with 67% improving, 21% persisting with IR, and 12% mortality.

Implications:

  • This study underscores the importance of investigating underlying causes for IR in children with IDDM, including autoimmune responses and comorbid conditions.
  • Early identification and tailored treatment strategies are essential for managing IR and improving outcomes in pediatric diabetes.
  • The findings contribute to the limited literature on insulin resistance in children, particularly highlighting rare associations like cystic fibrosis and hyperthyroidism.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.